In IKE-treated TIPE2−/− LLC tumor-bearing mice, increasing the accumulation of immunostimulatory MDSCs can promote effector CD4+ and CD8+ T cells, not immunosuppressive Tregs, to infiltrate into the tumor tissues. This evidence concerns the gene CD4 and neoplasm.